Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (151-160 of 304) with videos related to

Pageof 31
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patientsA L Jones, F MacNeill, S Jacobs, et al.
Cancer|January 9, 2001
Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinomaJ Chang, M Ormerod, T J Powles, et al.
Cancer|May 1, 1999
Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinomaA Makris, T J Powles, S Kakolyris, et al.
British Journal of Cancer|February 1, 1981
In vitro osteolytic activity of human breast carcinoma tissue and prognosisP J Dady, T J Powles, M Dowsett, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal womenK L Cheung, A Agrawal, E Folkerd, et al.
British Journal of Cancer|July 1, 1986
Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studiesA L Harris, G Hughes, A J Barrett, et al.
Breast Cancer Research and Treatment|April 16, 1998
Variation in endometrial thickening in women with amenorrhea on tamoxifenJ Chang, T J Powles, S E Ashley, et al.
Breast Cancer Research and Treatment|April 28, 2017
Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancerA Sheri, I E Smith, M Hills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancerJ Geisler, S Detre, H Berntsen, et al.
Breast Cancer Research and Treatment|May 19, 2000
Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapyR K Gregory, T J Powles, J Salter, et al.
Pageof 31

Showing results (151-160 of 304) with videos related to

Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patientsA L Jones, F MacNeill, S Jacobs, et al.
Cancer|January 9, 2001
Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinomaJ Chang, M Ormerod, T J Powles, et al.
Cancer|May 1, 1999
Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinomaA Makris, T J Powles, S Kakolyris, et al.
British Journal of Cancer|February 1, 1981
In vitro osteolytic activity of human breast carcinoma tissue and prognosisP J Dady, T J Powles, M Dowsett, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal womenK L Cheung, A Agrawal, E Folkerd, et al.
British Journal of Cancer|July 1, 1986
Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studiesA L Harris, G Hughes, A J Barrett, et al.
Breast Cancer Research and Treatment|April 16, 1998
Variation in endometrial thickening in women with amenorrhea on tamoxifenJ Chang, T J Powles, S E Ashley, et al.
Breast Cancer Research and Treatment|April 28, 2017
Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancerA Sheri, I E Smith, M Hills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancerJ Geisler, S Detre, H Berntsen, et al.
Breast Cancer Research and Treatment|May 19, 2000
Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapyR K Gregory, T J Powles, J Salter, et al.
Pageof 31